Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy

Published:2024-06-03 Issue:1 Volume:15 Page:361-373
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Valdez Benigno C.¹,Tsimberidou Apostolia M.²,Yuan Bin¹,Nieto Yago¹,Baysal Mehmet A.²,Chakraborty Abhijit²,Andersen Clark R.³,Andersson Borje S.¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

2. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Publisher

Impact Journals, LLC

Reference50 articles.

1. Roles of histone acetyltransferases and deacetylases in gene regulation;Allis;Bioessays,1998

2. Histone deacetylases and cancer;Seto;Oncogene,2007

3. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs;Bae;Am J Transl Res,2011

4. Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma;Anderlini;Cancer,2016

5. Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy;Andersson;Oncotarget,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP